The Therapy of Primary Adult Systemic CD30-Positive Anaplastic Large Cell Lymphoma: Results of 40 Cases Treated in a Single Center

References

• Schwab U., Stein H., Gerdes J., Lemke H., Kirchner H., Schaadt M., Diehl V. Production of a monoclonal antibody specific for Hodgkin and Stemberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299: 65–7
   PubMed Web of Science ®Google Scholar
• Stein H., Gerdes J., Schwab U., Lemke H., Mason D. Y., Ziegler A., Schienle W., Diehl V. Identification of Hodgkin and Stemberg-Reed cells as a unique cell type derived from a newly-detected small cell population. Int J Cancer. 1982; 30: 445–51
   PubMed Web of Science ®Google Scholar
• Stein H., Mason D. Y., Gerdes, Oconnor N., Wainscoat J., Pallesen G., Gatter K., Falini B., Delsol G., Lemke H., Schwarting R., Lennert K. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Stemberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–58
   PubMed Web of Science ®Google Scholar
• Ki-1 lymphoma: experience and clinical findings. Third Inrernaltional Conference on Malignant Lymphoma. 1987, H. Stein, J. Gerds, G. Tippelmann, D. Dienemann, R. Schwarting, N. O'Connor, S. Pileri, G. Pallesen, G. Delsol. LuganoSwitzerland 1987, June 10–3 (abstr.).
   Google Scholar
• Kadin M. E. Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol. 1994; 5: S25–S30
   Web of Science ®Google Scholar
• Agnarsson B. N., Kadin E. D. Ki-1 positive large cell lymphoma. Am J Surg Parhol. 1988; 12: 264–274
   PubMed Web of Science ®Google Scholar
• Stansfeld A. G., Diebold J., Kapanci Y., Kelenyi G., Lannert K., Miodusxwska O., Noel H., Rielke F., Sundstrom C., Van Unnik J. A. M., Wright H. D. Updated Kiel Classification for lymphomas. Luncer 1988; 1: 292–3
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K. C., Clearly M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H. K., Pileri S., Pins M. A., Ralfkaier E., Wamke R. A. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 34: 1361–92
   Google Scholar
• Pileri S., Falini B., Delsol G., Stein H., Baglioni P., Poggi S., Martelli M. F., Rivano M. T., Mason D. Y., Stansfeld A. G. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 with a high content of reactive histiocytes). Histopathology 1990; 16: 383–91
   PubMed Web of Science ®Google Scholar
• Stein H., Herbst H., Anagnostopoulos I. The nature of Hodgkin and Reed-Steinberg cells, their association with EBV. and their relationship to anaplastic large cell lymphoma. Ann Oncol. 1991; 2: 33–8
   PubMed Web of Science ®Google Scholar
• Moms S. W., Kirsten M. N., Valentine M. B., Dittmer K. G., Shapiro D. N., Saltman D. L., Look A. T. Fusion of a kinase gene ALK. to a nucleolar protein gene, NPM, in non Hodgkin's lymphoma. Science 1994; 263: 1281–4
   PubMed Web of Science ®Google Scholar
• Pileri S., Bocchia M., Baroni C. D., Martelli M., Falini B., Sabattini E., Gherlinzoni F., Amadori S., Poggi S., Mazza P., Burgio V., Zinzani P. L., Melilli G., Benni M., Saragoni L., Martelli M. F., Stein H., Mandelli F., Tura S. Anaplastic large cell lymphoma (CD30+Ki-l+): results of a prospective clinico-pathological study of 69 cases. Brit J Haematol. 1994; 86: 513–23
   PubMed Web of Science ®Google Scholar
• Mason D. Y., Bastard C., Rimokh R., Dastugue N., Huret J. L., Kristofferson U., Magaud J. P., Nezelof C., Tilly H., Vannier J. P., Hemet J., Wamke R. CD30 positive cell lymphomas (Kil lymphomas) are associated with a chromosomal translocation involving 5q35. Br J Haematol. 1990; 74: 161–8
   PubMed Web of Science ®Google Scholar
• Lamant L., Meggetto F., Al Saati Brugnieres L., Bressac de Paillerets B., Dastugue N., Berbinheim A., Rubie H., Ter-rier-Lacombe M. J., Robert A., Brousset P., Rigal F., Schlaifer D., Shirota M., Mori S., Delsol G. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 1996; 87: 28491
   Google Scholar
• Sarris A. H., Luthra R., Papadimitracopoulou V., Waasdorp M., Meletios A., Dimopoulos J. A., McBride J. A., Cabanil-Las F., Duvic M., Deisseroth A., Moms S. W., Pugh W. C. Amplification of genomic DNA demonstrates the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, but not other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Blood 1996; 88: 1771–9
   PubMed Web of Science ®Google Scholar
• Rosso R., Paulli M., Magrini U., Kindl S., Boveri E., Volpato G., Poggi S., Baglioni P., Pileri S. Anaplastic large cell lymphoma, CD30/Ki-l positive, expressing theCD15/Leu-Ml antigen. Virchows Arch B. 1989; 416: 229–32
   Google Scholar
• Engelhard M., Brittinger G., Huhn D., Gerhartz H. H., Meusers P., Siegert W., Thiel E., Wilmanss W., Aydermir U., Bierwolf S., Griesser H., Tiemann M., Lennert K. Subclassification of diffuse large B-cell lymphomas according to the Kiel Classification: distinction of centro-blastic and immunoblastic lymphomas is a significant prognostic risk factor. Blood 1997; 89: 2291–7
   PubMed Web of Science ®Google Scholar
• Zinzani P. L., Bendandi M., Martelli M., Falini B., Sabattini E., Amadori S., Gherlinzoni F., Martelli M. F., Mandelli F., Tura S., Pileri S. A. Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. J Clin Oncol. 1996; 14: 955–62
   PubMed Web of Science ®Google Scholar
• Filippa D. A., Ladanyi M., Wollner N., Straw D. J., O'Brien J. P, Gangi M., Sun M. CD30 (Ki-1)-positive malignant lymphomas: clinical, immu-nophenotypic. histologic, and genetic characteristics and differences with Hodgkin's disease. Blood 1996; 87: 2905–17
   PubMed Web of Science ®Google Scholar
• Tilly H., Gaulard P., Lepage E., Dumontet C., Diebold J., Plantier I., Berger F., Symann M., Petrella T., Lederlin P., Briere J. Primary anaplastic large- cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997; 90: 3727–34
   PubMed Web of Science ®Google Scholar
• Fanin R., Silvestri F., Geromin A., Cerno M., Infanti L., Zaja F., Barillari G., Savignano C., Rinaldi C., Damiani D., Buffoli A., Biffoni F., Baccarani M. Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with F-MACHOP regimen (radiotherapy) and autologous bone marrow transplantation. Blood 1996; 87: 1243–8
   PubMed Web of Science ®Google Scholar
• Fanin R., Silvestri F., Geromin A, Cerno M., Infanti L., Zaja F., Barillari G., Savignano C., Rinaldi C., Damiani D., Buffoli A., Biffoni F., Baccarani M. Sequential intensive treatment with the F-MACHOP regimen (radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma in adults. Leuk Lymph. 1997; 24: 369–77
   PubMed Web of Science ®Google Scholar
• Fanin R., Silvestri F. Therapy of primary systemic CD30-positive anaplastic large cell lymphoma of the adult. J Clin Oncol. 1996; 14: 3049–51
   PubMed Web of Science ®Google Scholar
• Oken M. M., Creech R. H., Tormey D. C., Horton J., Davis T. E., McFadden E. T., Carbone P. P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5: 649–55
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's Lymphoma. N Engl J Med. 1993; 329: 987–94
   PubMed Web of Science ®Google Scholar
• Zaja F., Russo D., Silvestri F., Fanin R., Infanti L., Bendini M., Zuiani C., Englaro E., Cattaruzzi E., Guerra P. Computed Tomography, Magnetic Resonance and Gallium 67 Scintigraphy for the imaging of residual lymphoma. Haematologica 1995; 80: 59–71
   Google Scholar
• Infanti L., Silvestri F., Fanin R., Salmaso F., Zaja F., Barillari G., Patriarca F., Geromin A., Cerno M., Damiani D, Baccarani M. The F-MACHOP regimen in the treatment of aggressive Non-Hodgkin's Lymphomas: a single centre experience in 72 patients. Haematologica 1996; 81: 521–8
   PubMedGoogle Scholar
• Chan J. K. C., Ng C. S., Hui P. K., Leung T. W., Lo E. S. F., Lau W. H., McGuire L. J. Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological typs. Histopathol. 1989; 15: 11–34
   PubMed Web of Science ®Google Scholar
• Tashiro K., Kikuchi M., Takeshita M., Yoshida T., Ohs-Hima K. Clinicopathological Study of Ki-1 positive lymphomas. Path Res Pract. 1989; 185: 461–7
   PubMed Web of Science ®Google Scholar
• Chott A., Kaserer K., Augustin I., Vesely M., Heinz R., Oehilinger W., Hanak H., Radaszkiewicz T. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Path. 1990; 14(5)439–48
   PubMed Web of Science ®Google Scholar
• Nakamura S., Takagi N., Kojima M., Motoori T., Kitoh K., Osada H., Suzuki H., Ogura M., Kurita S., Oyama A., Ueda R., Takahashi T., Suchi R. Clinicopathologic study of large cell anaplastic lymphoma (k-I-positive large cell lymphoma) among the Japanese. Cancer 1991; 68: 118–29
   PubMed Web of Science ®Google Scholar
• Penny R. J., Blaustein J. C., Longtine A. J., Geraldine S. P. Ki-I-positive large cell lymphomas, a heterogenous group of neoplasms. Morphologic, immunophenotypic, genotypic and clinical features of 24 cases. Cancer 1991; 68: 362–373
   PubMed Web of Science ®Google Scholar
• Greer J. P., Kinney M. C., Collins R. D., Saalhany K. E., Wolff S. N., Hainsworth J. D., Flexner J. M., Stein R. S. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol. 1991; 9: 539–47
   PubMed Web of Science ®Google Scholar
• De Bruin P. C., Beljaards R. C., Van Heerde P., Van Der Valk P., Noorduyn L. A., Van Kneken J. H. J. M., Kluin-Nelemans J. C., Willemze R., Meijer C. J. L. M. Differences in clinical behaviour and immunopheno-type between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathol. 1993; 23: 127–35
   PubMed Web of Science ®Google Scholar
• Shulman L. N., Frisard B., Antin J. H., Wheeler C., Pinkus G., Magauran N., Mauch P., Nobles E., Mashal R., Canellos G., Tung N., Kadin M. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol. 1993; 11: 937–42
   PubMed Web of Science ®Google Scholar
• Romaguera J. E., Manning J. T., Tornos C. S., Rodriguez J., Brooks T. E., Pugh W. C., Ordonez N. G., Goodacre A. M., Cabanillas F. Long term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma. Ann Oncol. 1994; 5: 317–22
   PubMed Web of Science ®Google Scholar
• Tirelli U., Vaccher E., Zagonel V., Talamini R., Bernardi D., Tavio M., Gloghini A., Merola A. C., Monfardini S., Carbone A. CD30 (ki-l)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol. 1995; 13: 373–80
   PubMed Web of Science ®Google Scholar
• Longo G., Federico M., Pieresca C., Avanzini P., Iannitto E., Di Prisco A. U., Baldini L., Brugiatelli M., Cl V., Bev-Ini M., Silingardi V. Anaplastic large cell lymphoma (CD30+Ki-I+). Analysis of 35 cases followed at GISL centres. Eur J Cancer. 1995; 310A: 1763–7
   Web of Science ®Google Scholar
• Clavio M., Rossi E., Tnini M., Truini M., Carrara P., Ravetti J. L., Spriano M., Vimercati A. R., Santini G., Canepa L., Pieni I., Celesti L., Miglino M., Castellaneta A., Damasio E., Gobbi M. Anaplastic large cell lymphoma: a clinicopathologic study of 53 patients. Leuk Lymph. 1996; 22: 319–27
   PubMed Web of Science ®Google Scholar
• Zinzani P. L., Martelli M., Magagnoli Zaccaria, Ronconi A., Cantonetti F., Bocchia M., Mama R., Gobbi M., Falini B., Gherlinzoni F., Moretti L., De Renm A., Mazza P., Pavone E., Sabattini E., Amendola A., Bendandi M., Pileri SA, Mandelli F., Tura S. Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood 1998; 92: 790–794
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma. Blood 1997; 89: 3909–18
   PubMed Web of Science ®Google Scholar
• Gisselbrecht C., Gaulard P., Lepage E., Coiftier B., Briere J., Haioun C., Cazals-Hatem D., Bosly A, Xem L., Tilly H., Berger F., Bouhabdallah R., Diebold J. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Blood 1998; 92: 76–82, for the Groupe d'Etudies des Lymphomes de l'Adulte (GELA).
   PubMed Web of Science ®Google Scholar